- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: Akebia Therapeutics (AKBA)- Vadadustat FDA Approved AT LAST!!
Posted on 4/4/24 at 10:07 am to Fat Batman
Posted on 4/4/24 at 10:07 am to Fat Batman
2
Posted on 4/4/24 at 12:42 pm to Fat Batman
Yeah frick me as I don’t know and adoption potential. But then again there’s always a bear and a bull thesis.
The (limited) analysts still see ABKA between $4-6. Not that analyst coverage is the crystal ball.. but the three analysts I see are all bullish on the price.
The (limited) analysts still see ABKA between $4-6. Not that analyst coverage is the crystal ball.. but the three analysts I see are all bullish on the price.
Posted on 4/4/24 at 3:37 pm to Fat Batman
The author is an nurse. This is a hackjob opinion piece. Seeking alpha made everyone dumber by publishing this guys crap
This post was edited on 4/4/24 at 4:43 pm
Posted on 4/15/24 at 6:53 pm to LChama
Trading ~1.5x 2023 sales
Also trading 25% below my average cost
Posted on 5/9/24 at 8:13 am to LSUcam7
Pain
Posted on 5/9/24 at 12:43 pm to LSUcam7
$1.10 was an opportunity. I didn't take it.
Not concerned. Will revisit in a year.
Not concerned. Will revisit in a year.
Posted on 5/9/24 at 1:26 pm to bayoubengals88
If this thing has any legs at all this time next year it should be a bargain. I am thinking of grabbing a few more shares and just rolling the dice.
Posted on 6/21/24 at 9:01 am to tigerfoot
AKBA launched Vafseo in Germany and Austria earlier this month. It’s available in 37 countries thus far with the US approval.
$170M revenues from Auryxia and AKBA is parlaying those relationships into Vafseo contracts. AKBA expecting very modest revenue growth from that $170M for 2024, without any Vafseo revenues.
TDAPA designation wrapped up in Jan ‘25.
$42M cash that should carry the company’s op ex at least through 2025. Expenses clear as AKBA solely focused on launch and holding off taking pre-clinical assets into the clinic.
AKBA market cap $200M as of 6/21.
$170M revenues from Auryxia and AKBA is parlaying those relationships into Vafseo contracts. AKBA expecting very modest revenue growth from that $170M for 2024, without any Vafseo revenues.
TDAPA designation wrapped up in Jan ‘25.
$42M cash that should carry the company’s op ex at least through 2025. Expenses clear as AKBA solely focused on launch and holding off taking pre-clinical assets into the clinic.
AKBA market cap $200M as of 6/21.
Posted on 6/21/24 at 12:08 pm to LSUcam7
F it. bought 2000 shares.
Posted on 6/21/24 at 12:20 pm to Neauxla
I think I might add soon as well.
Then completely ignore it for 6-12mos.
Then completely ignore it for 6-12mos.
Posted on 6/21/24 at 4:19 pm to LSUcam7
im going to grab another 1000 shares if it stays down below a buck. Looks like some directors are acquiring shares, so maybe I take a little bit more of a position. That woudl give me. 3500 or so. If it pops up to 3 bucks I will be happy as a clam.
I promised myself I would not do this type of chasing deal again, but this one seems to have an actual product
I promised myself I would not do this type of chasing deal again, but this one seems to have an actual product
Posted on 6/26/24 at 9:57 am to tigerfoot
AKBA has market cap less than analysts’ expected revenue of ~$180M.
This bag is heavy.
This bag is heavy.
Posted on 6/26/24 at 10:12 am to LSUcam7
Lovin' the second chance here. Incredible that FDA rejection sent it from $2.40 to .70 then down to .26 while approval also sends it to .80 and possibly lower.
Beautiful set up going into Q1 '25.
Beautiful set up going into Q1 '25.
Posted on 6/27/24 at 9:19 am to bayoubengals88
Whiplash 
Posted on 7/16/24 at 12:50 pm to bayoubengals88
+65% move off of those 6/25 lows.
Still down but I bought 1/3rd of the position at that $0.85 mark.
Still down but I bought 1/3rd of the position at that $0.85 mark.
Posted on 7/16/24 at 12:59 pm to LSUcam7
quote:
Still down but I bought 1/3rd of the position at that $0.85 mark.
Bought more from 1.17 down to .93
I totally missed the big news last week.
Saw the big day but didn't know material news was driving it.
Akebia now owns full rights Vafseo after ending their licensing deal with Vifor. Nice!
Also listed an annuel price of 15.5k on the low end. Very affordable!
This thing really should kick arse next year.
Posted on 7/16/24 at 1:10 pm to bayoubengals88
quote:
This thing really should kick arse next year.
I'll continue to stack shares!
Posted on 7/16/24 at 4:11 pm to bayoubengals88
cliffs on this penny stock?
Posted on 7/16/24 at 5:51 pm to DoomGuy504
that stretch was painful. Those adds at 1.99 hurt but average is still 1.19 in taxable account and .86 in 401k account. Should continue to climb but 2025 should be a great year.
Posted on 7/17/24 at 12:55 pm to donRANDOMnumbers
quote:FDA approval granted in March after initial rejection. By next year they'll have two commercial drugs. The one that just got approved has potential to see in the upper hundreds of million dollars per year.
cliffs on this penny stock?
Page 19 of 20
Popular
Back to top
Follow TigerDroppings for LSU Football News